Skip to main content
. Author manuscript; available in PMC: 2019 Oct 1.
Published in final edited form as: Oncogene. 2018 Dec 17;38(16):2923–2936. doi: 10.1038/s41388-018-0601-9

Table 1.

Univariable and Multivariable analyses of clinic-pathologic parameters of overall survival in patient with GBM

UVA MVA

Parameter HR 95% CI P value HR 95% CI P value
Gender Categorical 1.13 0.85–1.50 0.39 1.23 0.92–1.64 0.16
Age Continuous 1.03 1.02–1.04 <0.001 1.00 0.99–1.02 0.23
KPS-70 < 70 vs 70 and above 0.55 0.40–0.76 <0.001 0.91 0.64–1.29 0.60
Treatment None vs TMZ or IR alone 0.12 0.07–0.20 <0.001 0.12 0.070–0.21 <0.001
Treatment None vs TMZ+IR (Stupp protocol) 0.03 0.02–0.05 <0.001 0.04 0.02–0.06 <0.001
miR-4516 Continuous 1.29 1.12–1.48 <0.001 1.49 1.12–1.99 0.01